OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases
Tamsin Cargill, Emma Culver
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Primary biliary cholangitis
Atsushi Tanaka, Xiong Ma, Atsushi Takahashi, et al.
The Lancet (2024) Vol. 404, Iss. 10457, pp. 1053-1066
Open Access | Times Cited: 20

Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease
Naomi Richardson, Grace Wootton, Amber G. Bozward, et al.
Seminars in Immunopathology (2022) Vol. 44, Iss. 4, pp. 461-474
Open Access | Times Cited: 36

Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Mengyao Yan, Shuli Man, Long Ma, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 620-648
Open Access | Times Cited: 7

Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases
Agata Mostkowska, Guy Rousseau, Noël J.‐M. Raynal
The FASEB Journal (2024) Vol. 38, Iss. 5
Open Access | Times Cited: 6

Immunosuppressive drugs modes of action
María Meneghini, Oriol Bestard, Josep M. Grinyó
Best Practice & Research Clinical Gastroenterology (2021) Vol. 54-55, pp. 101757-101757
Open Access | Times Cited: 39

Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
Jinyu Zhao, Ping Yue, Ningning Mi, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 326-365
Closed Access | Times Cited: 4

Insights Gained Into the Injury Mechanism of Drug and Herb Induced Liver Injury in the Hepatic Microenvironment
Xiaomeng Zhang, Qi Geng, Lin Lin, et al.
Toxicology (2024) Vol. 507, pp. 153900-153900
Closed Access | Times Cited: 4

Upadacitinib for refractory Primary Biliary Cholangitis
Mirjam Kolev, Burkhard Möller, Annalisa Berzigotti, et al.
Journal of Hepatology (2025)
Closed Access

The Role of B Cells in Adult and Paediatric Liver Injury
Arzoo Patel, Yuxin S. Liu, Scott Davies, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 26

Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis
Kozue Kanemitsu‐Okada, Masanori Abe, Yoshiko Nakamura, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2509-2509
Open Access | Times Cited: 7

Systemic lupus erythematosus and autoimmune hepatitis overlap disease in a hospitalized systemic lupus erythematosus cohort
Chrong‐Reen Wang, Hung‐Wen Tsai, I‐Chin Wu
Journal of the Formosan Medical Association (2024)
Open Access | Times Cited: 2

Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
Nana Zhang, Huimin Yao, Zhixuan Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6

Immunobiology of the biliary tract system
Niklas K. Björkström
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1657-1669
Open Access | Times Cited: 10

Inhibition of Bruton Tyrosine Kinase Reduces Neuroimmune Cascade and Promotes Recovery after Spinal Cord Injury
Yu Chen, Vimala Bondada, Hina Iqbal, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 355-355
Open Access | Times Cited: 14

The liver-resident immune cell repertoire - A boon or a bane during machine perfusion?
Margot Fodor, Stefan Salcher, H. Gottschling, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
Krishna Khandelwal, Vedika Jajoo, Kshitij Bajpai, et al.
Cureus (2023)
Open Access | Times Cited: 4

B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients
Eveline E. Vietsch, Diba Latifi, Maaike Verheij, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4

The immunological function of CXCR2 in the liver during sepsis
Na Liu, Michael Bauer, Adrian T. Press
Journal of Inflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 7

Autoimmune hepatitis and primary biliary cholangitis overlap disease in a systemic lupus erythematosus patient receiving long-term B-cell depletion therapy
Chrong‐Reen Wang, Hung‐Wen Tsai, I‐Chin Wu
Journal of the Formosan Medical Association (2023) Vol. 122, Iss. 11, pp. 1219-1220
Open Access | Times Cited: 2

Recent progress on the treatment of type 1 autoimmune pancreatitis and IgG4-related disease
Kazuichi Okazaki, Tsukasa Ikeura, Kazushige Uchida
Modern Rheumatology (2022) Vol. 33, Iss. 2, pp. 237-241
Closed Access | Times Cited: 4

Frequency of seronegative cases in autoimmune hepatitis and their association with the systemic immune inflammation index
Nermin Mutlu Bilgiç
Journal of Health Sciences and Medicine (2024) Vol. 7, Iss. 2, pp. 230-235
Open Access

STATE OF CELLULAR IMMUNITY IN PURULENT CHOLANGITIS
O. V. Maloshtan, R. M. Smachylo, A. A. Nekliudov, et al.
Kharkiv Surgical School (2024), Iss. 1, pp. 39-43
Closed Access

STATE OF CELLULAR IMMUNITY IN PURULENT CHOLANGITIS
O. V. Maloshtan, R. M. Smachylo, A. A. Nekliudov, et al.
Kharkiv Surgical School (2024), Iss. 4, pp. 40-44
Open Access

Autoimmune hepatitis: Towards a personalized treatment
Guillermo Costaguta, Guillermo Costaguta, Fernando Álvarez
World Journal of Hepatology (2024) Vol. 16, Iss. 11, pp. 1225-1242
Closed Access

Page 1 - Next Page

Scroll to top